Description
YONDELIS (trabectedin) is a prescription intravenous alkylating drug used in cancer treatment. It's manufactured by Janssen Products, LP as a lyophilized powder for injection, with each vial containing 1 mg of trabectedin. Approved under NDA207953, it's administered by healthcare professionals. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the FDA dataset for Trabectedin — ANDA 207953 submitted by Mylan Institutional LLC
|
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207953 |
Tags
- drug-information
- drug-manufacturers
- prescription-drugs
- drug
- medications